Amneal Pharmaceuticals (AMRX) Cash from Investing Activities Growth (1y) (2018 - 2026)
Amneal Pharmaceuticals (AMRX) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 13.93% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 57.14% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 551.55% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -3,664.79% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -3.45% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -22,919.16% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 140.78% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 52.90% |
| 10 | Amneal Pharmaceuticals | 4.84 Bn | 4.84 Bn | 320.11 Mn | -21.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.98% |
| Dec 31, 2025 | -183.04% |
| Sep 30, 2025 | -8.46% |
| Jun 30, 2025 | -310.63% |
| Mar 31, 2025 | 9.93% |
| Dec 31, 2024 | 49.33% |
| Sep 30, 2024 | -53.70% |
| Jun 30, 2024 | 47.37% |
| Mar 31, 2024 | -68.36% |
| Dec 31, 2023 | -176.40% |
| Sep 30, 2023 | 72.68% |
| Jun 30, 2023 | 23.78% |
| Mar 31, 2023 | 87.95% |
| Dec 31, 2022 | 86.82% |
| Sep 30, 2022 | -324.07% |
| Jun 30, 2022 | 80.56% |
| Mar 31, 2022 | -667.31% |
| Dec 31, 2021 | -173.53% |
| Sep 30, 2021 | 21.30% |
| Jun 30, 2021 | -828.50% |